Tanner Pharma Group to Attend CTS Europe, DCAT, PharmagoraPlus, PQMD, and GCSG US Conferences
For Immediate Release
Tanner Pharma Group
CHARLOTTE, N.C. – Key directors from Tanner Pharma Group (“Tanner Pharma”), a Charlotte-based global pharmaceutical services company, will attend several international healthcare conferences throughout the upcoming months of March and April. The team will join other global executives for the following events:
Clinical Trial Supply Europe | March 13th – 14th | Milan, Italy
DCAT Week | March 18th – 21st | New York City, New York
PharmagoraPlus | March 30th – 31st | Paris, France
PQMD Global Health Policy Forum | April 16th – 18th | Geneva, Switzerland
US GCSG Conference | April 28th – May 1st | San Antonio, Texas
Tanner Pharma leverages more than 16 years of pharma services experience. The company provides services through four synergistic divisions located in the U.S. and U.K.; TannerCTS, clinical trial services; TannerMAP, managed access programs, TannerLAC, licensing, acquisition and commercialization; and TannerGAP, global access programs.
Our CTS, MAP and Corporate Development teams will be attending these events. Representatives include Graeme Birrell, TannerCTS Business Development Lead, Jonathan Bracey, Managing Director UK – SVP of Corporate Development, and Rob Keel, Director for TannerMAP.
Individuals who wish to schedule a meeting with representatives from Tanner Pharma may contact:
Shona John | email@example.com | +44 (0) 20 3940 8117
About Tanner Pharma Group
Tanner Pharma Group is a global service provider in the healthcare industry with a core purpose of improving lives through increased access to medicines. Each of its four service divisions is built on a foundation of a robust distribution network with industry-leading quality standards. Founded in 2003, the company works with a broad range of companies to distribute life-saving medications to patients in more than 120 countries. For more information about Tanner Pharma Group, please visit www.tannerpharma.com.